Stanley Lewis

Company: A28 Therapeutics

Job title: Founder & Chief Executive Officer

Seminars:

Hormone-Peptide Conjugates: Next Generation Targeted Therapy 10:30 am

Exploring a paradigm shift in conjugate design, focusing on the mechanism rather than the molecule, to unlock new avenues for targeted therapy innovations Embracing innovation, this conjugate design bypasses traditional linker-based approaches, with the hormone directly fused to the lytic peptide, optimizing delivery and enhancing therapeutic efficacy Understanding how the unique design of hormone-linked lytic…Read more

day: Day Two